Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are known to impact the functional receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association between chronic therapy with these medications and infection risk remains unclear.
Renin–Angiotensin–Aldosterone System Inhibitors and SARS-CoV-2 Infection: An Analysis from the Veteran’s Affairs Healthcare System: Sandhu. ACEI, ARB, and Association with COVID
Workshop debate importância da rastreabilidade no combate à pirataria